This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Isomorphic Labs financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector. The post An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025 appeared first on MedCity News. Biotech financing activity has been slowing down, analysts say.
The post Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More appeared first on MedCity News. Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year.
The MedTech industry has demonstrated remarkable resilience in navigating uncertainty, and 2025 promises to be a pivotal year as the election supercycle concludes and AI regulatory frameworks become clearer. The post 10 Key MedTech Themes for 2025 appeared first on MedCity News.
Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World appeared first on MedCity News. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced cases of certain blood cancers. Takeda holds an exclusive option to develop and commercialize one of those drugs in most of the world.
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line.
The post Who is Speaking at INVEST 2025? The healthcare investor conference, scheduled for May 20 and 21 at the Willis Tower in Chicago, combines panel discussions, networking opportunities, and a startup pitch contest. Register today! appeared first on MedCity News.
Hospitals started 2025 with a stable financial performance driven by strong patient volumes, but rising costs for drugs, supplies, and services continue to put major pressure on margins. The post How Are Hospitals Faring Financially in 2025? appeared first on MedCity News.
Here are four trends expected to accelerate in 2025. The post 2025 Trends in Health IT appeared first on MedCity News. Technology often plays a critical role in strategies to combat rising costs while maintaining quality care.
📆 March 5, 2025 at 9:30am PT, 12:30pm ET, 5:30pm GMT . 🌟 Future Readiness: Gain actionable steps to prepare your marketing and sales teams for the AI-driven future. Be part of the conversation! Register now to explore the future of AI in sales and marketing!
Cargo is discontinuing the study and shifting focus to a different cell therapy on track to begin Phase 1 testing in mid-2025. Phase 2 data for Cargo Therapeutics CD22-targeting cell therapy show low durability and cases of a severe immune response, some that were classified as grade 4 or 5 serious adverse events.
Healthcare experts should be on the lookout for trends related to digital health, prescription drug costs and healthcare coverage in 2025, according to LRVHealth. The post 5 Healthcare Predictions for 2025 from One VC Firm appeared first on MedCity News.
As we all work to wrap up the year and enter into 2025, here are a few trends to keep your eye on in the coming months and beyond. The post 2025 and Beyond: Key Trends to Watch in Pharmacy appeared first on MedCity News.
Pharma-exclusive Webinar: The 2025 Pharma Toolkit for Virtual Medical Education About the webinar Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders.
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact.
Amid the chaos and confusion of healthcare IT in our age of AI, a triage concept may be the best guide for organizations fighting to stray strong and capable in 2025 and beyond. The post Healthcare IT in 2025: Triage for the Age of AI appeared first on MedCity News.
and European Union approvals in this indication in 2025. Novo Nordisk’s Wegovy achieved statistically significant improvement in a Phase 3 study in the fatty liver disease MASH. Based on these preliminary results, the company plans to seek U.S.
The post A Sneak Peek of INVEST 2025 Agenda appeared first on MedCity News. Among the topics INVEST will highlight are AI in life sciences, the investor perspective in healthcare and strategic priorities for hospitals.
The post Future Trends for Clinical Trials in 2025 and Beyond appeared first on MedCity News. Four key predictions for the future of clinical trials, examining how these changes will revolutionize the speed, efficiency, and reliability of bringing life-saving treatments to market.
📆 April 3, 2025 at 9:30am PT, 12:30pm ET, 4:30pm GMT . ⚡ The latest technology trends shaping the future of sales and customer engagement for long-term success. Register today to learn how to implement AI and automation in a way that enhances, not replaces, the human side of sales!
in 2025 appeared first on MedCity News. Global medical costs are expected to rise by double digits for the third year in a row, according to a recent survey from WTW. The post Report: Global Medical Costs Projected to Rise by 10.4%
The post Navigating Virtual Prescribing Policy Changes in 2025 appeared first on MedCity News. Through collaboration between regulators and healthcare stakeholders, telehealth prescribing can continue to expand treatment access while maintaining proven safety standards.
Zocdoc CEO Oliver Kharraz has some predictions about how healthcare will change in 2025 including the rise of cash-pay services and the potential restructuring of Amazons healthcare assets. The post Zocdoc CEO Predicts 3 Ways the Healthcare Industry Will Change in 2025 appeared first on MedCity News.
The post Top Priorities and Challenges for Digital Health Leaders in 2025: 5 Key Insights appeared first on MedCity News. About 79% of digital health leaders said their companies are pursuing new investment capital in the next year, according to a recent survey from Summit Health Advisors.
billion restructuring initiative that runs through 2025 may not be the end of the company’s ongoing efficiency push. | Bristol Myers' $1.5 billion restructuring initiative that runs through 2025 may not be the end of the company's ongoing efficiency push. Bristol Myers’ $1.5
After experiencing a series of ups and downs in recent years, the biopharma contracting business is gearing up for a rebound in 2025. Ahead of the CPHI conference in Milan, the events group has teased new research signaling an expected rebound for the CDMO industry—and a rejection of the BIOSECURE Act.
The post ViVE 2025: Shaping the Future of Virtual-first Care appeared first on MedCity News. Virtual care is no longer just a convenience, it is a necessity. The question is no longer whether virtual-first care is viable but how quickly we can make it the preferred model for modern healthcare.
GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), following a string of exits by companies including Pfizer, UCB, WuXi AppTec and | The company opted not to renew its membership for 2025 following an annual review of its trade group associations, a spokesperson said.
After pulling off a surprise third-quarter beat and full-year guidance raise amid shareholder activism earlier this year, Pfizer now expects its 2025 revenues to come in the same range as in 2024.<
In a sizable cost-cutting measure, Biogen will lay off 1,000 employees by 2025, it announced in presenting its second quarter earnings. In reporting its first-quarter earnings, Biogen said it would halt the development of at least four investigational drugs to allow the company to focus on more lucrative opportunities. |
first Humira biosim launch last year and its planned Stelara biosim rollout in 2025. first Humira biosim launch last year and its planned Stelara biosim rollout in 2025. Amgen has made waves in the biosimilar field in recent years with its U.S.-first Amgen has made waves in the biosimilar field in recent years with its U.S.-first
With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025. In 2025, AI-powered marketing tools and programmatic ad placements are driving efficiency and targeting precision.
The post Tips for Greater Healthcare Practice Success in 2025 appeared first on MedCity News. [Sponsored] Hidden costs can undermine your healthcare practice. A webinar sponsored by Elation Health will offer insights on how to address them.
Eleven medicines, covering key areas such as gene therapy, as well as drugs for obesity and oncology, are anticipated to attain blockbuster status or be therapeutic game-changers globally within five years to 2030, according to the 2025 edition of the Drugs to Watch report.
In 2025, the strategies that succeed are rooted in personalization, innovation, and real-time adaptability. In 2025, the ability to react to these preferences in near real time is what separates leading pharma marketing teams from the rest. FAQs What is the biggest trend in marketing in pharma in 2025?
Jazz aims to complete its search for a CEO successor by the end of 2025, after which Cozadd will stay on board as the drugmaker's board chair. . | Current helmsman Bruce Cozadd plans to retire from his role at Jazz Pharmaceuticals in the next 12 months, the company said Monday.
[Sponsored] Executives from EY, Genzeon, ProviderTrust, SmarterDx, and symplr shared insights about their businesses in interviews at the ViVE 2025 conference in Nashville this month. The post The Vibe at ViVE: Health Tech Leaders Discuss Plans for 2025 appeared first on MedCity News.
Reuters Pharma USA 2025 will unite senior pharma leaders across commercial, marketing, medical affairs, patient engagement, market access, real world evidence and data for two days of learnings in Philadelphia. Register Now The post Reuters Pharma USA 2025 appeared first on Pharma Marketing Network.
In this report, 15 of our experts examine the current impact of each of these three forces, predict how you’ll see their effects in 2025 and give recommendations for how to make these market forces work for you. Over the coming weeks, you’ll be seeing a lot of forecasts for 2025. And this isn’t an anonymous think piece.
As companies begin to make plans for 2025, add the INVEST Pitch Perfect Contest to your calendar. The post Are You a Startup Looking for an Audience of Investors? We Have The Perfect Pitch Contest for You! appeared first on MedCity News.
As we step into 2025, here are the key trends shaping the future of pharmaceutical marketing. By 2025, an integrated omnichannel approach will be the dominant strategy, ensuring consistent messaging across multiple touchpoints. AI-driven content optimisation tailors marketing materials to suit the individual preferences of each doctor.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content